LINC01252

Across TCGA pan-cancer cohorts, LINC01252 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC01252 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01252 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01252 expression acts as an unfavorable survival marker, although some lineages such as LIHC and PAAD show a favorable association.

UVM, LIHC, and PAAD are the cancer types where LINC01252 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.396	0.789	<.001	149	view →
LIHC	OS	Quartile	All	0.880	0.679	<.001	97	view →
PAAD	OS	Quartile	All	0.663	0.417	.008	17	view →
LUAD	DFS	Median	III,IV	0.655	0.371	.007	16	view →
SKCM	OS	Tertile	IV	0.849	0.277	.008	14	view →
STAD	DFS	Median	IV	0.134	0.503	.001	12	view →
ESCA	OS	Median	III,IV	0.559	0.322	.011	12	view →
HNSC	DFS	Median	All	0.759	0.662	.012	10	view →
ACC	DFS	Quartile	III,IV	0.801	0.196	.012	9	view →
LUSC	DFS	Median	II,III,IV	0.273	0.466	.013	7	view →
UCS	OS	Tertile	II,III,IV	0.309	0.655	.013	6	view →
KICH	DFS	Tertile	III,IV	0.382	1.000	.027	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC01252–UVM (DFS)

Open the UVM breakdown →